| NCT ID | NCT06302777 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Goethe University |
| Condition | Coronary Artery Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2023-09-26 |
| Primary Completion | 2028-09-26 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2023-09-26 with a primary completion date of 2028-09-26.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
All comers registry with patients with chronic coronary syndrome or acute coronary syndrome who underwent intracoronary imaging during cardiac catherization. The aim is to identify plaque characteristics on OCT or IVUS that are associated with adverse cardiac events including myocardial infarction and atherosclerotic progression.
Eligibility Criteria
Inclusion Criteria: patients undergoing pre-intervention optical coherence tomography imaging Exclusion Criteria: \-
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06302777 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Coronary Artery Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06302777 currently recruiting?
Yes, NCT06302777 is actively recruiting participants. Contact the research team at lena.seegers@herz-frankfurt.de for enrollment information.
Where is the NCT06302777 trial being conducted?
This trial is being conducted at Frankfurt am Main, Germany, Frankfurt, Germany.
Who is sponsoring the NCT06302777 clinical trial?
NCT06302777 is sponsored by Goethe University. The trial plans to enroll 500 participants.